A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty

Completed · Phase 3 · Has a placebo group

Conditions studied: Acute Pain

In brief

The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a Abdominoplasty.

Key facts

Study ID

NCT06545097

Run by

Tris Pharma, Inc.

People needed

279

Starts

2024-09-03

Expected to finish

2024-12-30

Last updated by the study team

2026-01-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

Where it is running

• ALLEVIATE 1 Site 001106 — Little Rock, Arkansas, United States
• ALLEVIATE 1 Site 001112 — Miami, Florida, United States
• ALLEVIATE 1 Site 001110 — Bellaire, Texas, United States
• ALLEVIATE 1 Site 001111 — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.